Clinical Trials on Adenocarcinoma of Prostate in New Zealand
Total 5085 results
-
Memorial Sloan Kettering Cancer CenterCompletedMRI | Prostate CancerUnited States
-
PROCEPT BioRoboticsRecruitingLocalized Prostate CancerUnited States
-
Yale UniversityCompleted
-
NYU Langone HealthTerminatedProstate CancerUnited States
-
New Mexico Cancer Care AllianceTerminatedProstate CancerUnited States
-
Progenics Pharmaceuticals, Inc.CompletedProstate CancerUnited States
-
Roswell Park Cancer InstituteCompleted
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
New York Prostate InstituteSanofiUnknownProstate CancerUnited States
-
DisperSol Technologies, LLCTranslational Drug DevelopmentActive, not recruiting
-
Constellation PharmaceuticalsActive, not recruitingMetastatic Castration Resistant Prostate Cancer (mCRPC)United States
-
Merck Sharp & Dohme LLCRecruitingMetastatic Castration-Resistant Prostate CancerUnited States, Austria, Canada, France, Germany, Ireland, Italy, Mexico, Netherlands, New Zealand, Poland, Sweden, Taiwan, Turkey, Ukraine, United Kingdom, Spain, Finland, Australia, Denmark
-
AstraZenecaRecruitingMetastatic Prostate CancerUnited States, Australia
-
Stony Brook UniversityProgenics Pharmaceuticals, Inc.CompletedProstate CancerUnited States
-
Royal North Shore HospitalCompleted
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstate CancerUnited States
-
Astellas Pharma IncAgensys, Inc.CompletedProstate CancerUnited States
-
Astellas Pharma IncOSI Pharmaceuticals; Cell PathwaysCompleted
-
Department of Veterans Affairs, New JerseyPfizerUnknownA Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate CancerProstate CancerUnited States
-
Department of Veterans Affairs, New JerseySanofi; PfizerUnknownProstate CancerUnited States
-
Oxford BioMedicaMedSource LLCTerminatedHormone Refractory Prostate CancerUnited States
-
Molecular Insight Pharmaceuticals, Inc.CompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; University of Colorado, Denver; Northwell HealthTerminatedProstate CancerUnited States
-
St George Hospital, AustraliaRecruiting
-
University of Texas Southwestern Medical CenterCompletedStereotactic Ablative Radiotherapy (SABR) for Low Risk Prostate Cancer With Injectable Rectal SpacerProstate CancerUnited States
-
Royal North Shore HospitalUniversity of SydneyCompleted
-
Precision Biopsy, Inc.Suspended
-
Precision Biopsy, Inc.UnknownProstate CancerUnited States
-
Peter MacCallum Cancer Centre, AustraliaCompletedMetastatic Castration Resistant Prostate CancerAustralia
-
Ascenta TherapeuticsCompletedHormone Refractory Prostate CancerUnited States, Russian Federation
-
National Cancer Institute (NCI)TerminatedMucinous Adenocarcinoma of the Rectum | Signet Ring Adenocarcinoma of the Rectum | Mucinous Adenocarcinoma of the Colon | Signet Ring Adenocarcinoma of the Colon | Recurrent Colon Cancer | Recurrent Rectal Cancer | Stage IVA Colon Cancer | Stage IVA Rectal Cancer | Stage IVB Colon Cancer | Stage IVB Rectal...United States
-
Icahn School of Medicine at Mount SinaiCompletedProstatic Neoplasms | Prostate Cancer | Prostate NeoplasmsUnited States
-
GP-PharmTerminatedProstate CancerUnited States
-
Boston Scientific CorporationSuspendedCancer | ProstateUnited States
-
NYU Langone HealthNovartisCompletedProstatic Neoplasms | Prostate CancerUnited States
-
Vanderbilt UniversityPatient-Centered Outcomes Research Institute; M.D. Anderson Cancer Center; Emory... and other collaboratorsCompletedProstate CancerUnited States
-
Rutgers, The State University of New JerseyMemorial Sloan Kettering Cancer Center; Fox Chase Cancer Center; Rutgers Cancer...CompletedProstate Cancer | Sexuality | Sexual Dysfunction and InfertilityUnited States
-
Royal North Shore HospitalWithdrawn
-
BioProtectCompletedProstate CancerUnited States
-
Biotech Equity Partners Pty LtdUnknownProstate CancerAustralia
-
Weill Medical College of Cornell UniversityConvergent Therapeutics, Inc.WithdrawnProstate Cancer MetastaticUnited States
-
Astellas Pharma Global Development, Inc.PfizerCompletedProstate Cancer | Castration-resistant Prostate Cancer | Metastatic Prostate CancerUnited States
-
Eli Lilly and CompanySarah Cannon Development InnovationsCompletedProstate Cancer MetastaticUnited States
-
Northwell HealthAmerican Cancer Society, Inc.CompletedProstate CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyCompletedProstate CancerUnited States
-
National Cancer Institute (NCI)CompletedAdenocarcinoma of the Gastroesophageal Junction | Stage IV Gastric Cancer | Recurrent Gastric Cancer | Diffuse Adenocarcinoma of the Stomach | Intestinal Adenocarcinoma of the Stomach | Mixed Adenocarcinoma of the Stomach | Stage IIIB Gastric Cancer | Stage IIIC Gastric CancerUnited States
-
Novartis PharmaceuticalsCompletedCastration-resistant Prostate CancerFrance, Spain, Canada, Belgium, United Kingdom, United States
-
Peter MacCallum Cancer Centre, AustraliaRecruitingMetastatic Castration Resistant Prostate Cancer (mCRPC)Australia
-
University of Wisconsin, MadisonMadison Vaccines IncorporatedCompletedProstate CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyCompletedProstate CancerUnited States